Journal of Internal Medicine Concepts & Practice ›› 2022, Vol. 17 ›› Issue (03): 181-185.doi: 10.16138/j.1673-6087.2022.03.001
• Experts forum • Next Articles
Received:2022-01-05
Online:2022-05-30
Published:2022-08-09
CLC Number:
| [1] | George S, Aline B. Osteoimmunology[M]//Marc CH, Alan JS, Josef SS, et al. Rheumatology. 6th ed. Philadelphia, USA: Elsevier Mosby, 2015: 165-168. |
| [2] | Horton JE, Raisz LG, Simmons HA, et al. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes[J]. Science, 1972, 177(4051): 793795. |
| [3] |
Mundy GR, Luben RA, Raisz LG, et al. Bone-resorbing activity in supernatants from lymphoid cell lines[J]. New Engl J Med, 1974, 290(16): 867-871.
pmid: 4816960 |
| [4] |
Srivastava RK, Dar HY, Mishra PK. Immunoporosis: immunology of osteoporosis-role of T cells[J]. Front Immunol, 2018, 9: 657.
doi: 10.3389/fimmu.2018.00657 pmid: 29675022 |
| [5] |
Ke K, Sul OJ, Chung SW, et al. Lack of NOD2 attenuates ovariectomy-induced bone loss via inhibition of osteoclasts[J]. J Endocrinol, 2017, 235(2): 85-96.
doi: 10.1530/JOE-16-0591 pmid: 28778866 |
| [6] |
Souza PPC, Lerner UH. Finding a Toll on the route: the fate of osteoclast progenitors after Toll-like receptor activation[J]. Front Immunol, 2019, 10: 1663.
doi: 10.3389/fimmu.2019.01663 URL |
| [7] |
Plotkin LI, Essex AL, Davis HM. RAGE signaling in skeletal biology[J]. Curr Osteoporos Rep, 2019, 17(1): 16-25.
doi: 10.1007/s11914-019-00499-w pmid: 30685821 |
| [8] |
Karner CM, Long F. Glucose metabolism in bone[J]. Bone, 2018, 115: 2-7.
doi: 10.1016/j.bone.2017.08.008 URL |
| [9] |
Chang MK, Raggatt LJ, Alexander KA, et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo[J]. J Immunol, 2008, 181(2):1232-1244.
pmid: 18606677 |
| [10] |
Huang R, Wang X, Zhou Y, et al. RANKL-induced M1 macrophages are involved in bone formation[J]. Bone Res, 2017, 5: 17019.
doi: 10.1038/boneres.2017.19 pmid: 29263936 |
| [11] |
Dou C, Ding N, Zhao C, et al. Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice[J]. J Bone Miner Res, 2018, 33(5): 899-908.
doi: 10.1002/jbmr.3364 pmid: 29281118 |
| [12] |
Omata Y, Frech M, Primbs T, et al. Group 2 innate lymphoid cells attenuate inflammatory arthritis and protect from bone destruction in mice[J]. Cell Rep, 2018, 24(1):169-180.
doi: 10.1016/j.celrep.2018.06.005 URL |
| [13] |
Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand[J]. Nature, 1999, 402(6759): 304-309.
doi: 10.1038/46303 URL |
| [14] |
Pugliese LS, Gonçalves TO, Popi AF, et al. B-1 lymphocytes differentiate into functional osteoclast-like cells[J]. Immunobiology, 2012, 217(3): 336-344.
doi: 10.1016/j.imbio.2011.07.014 pmid: 21855167 |
| [15] |
Fujiwara Y, Piemontese M, Liu Y, et al. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients[J]. J Biol Chem, 2016, 291: 24838-24850.
pmid: 27733688 |
| [16] |
Adami G, Fassio A, Rossini M, et al. Osteoporosis in rheumatic diseases[J]. Int J Mol Sci, 2019, 20(23): 5867.
doi: 10.3390/ijms20235867 URL |
| [17] |
Orsolini G, Caimmi C, Viapiana O, et al. Titer-dependent effect of anti-citrullinated protein antibodies on systemic bone mass in rheumatoid arthritis patients[J]. Calcif Tissue Int, 2017, 101(1): 17-23.
doi: 10.1007/s00223-017-0253-8 URL |
| [18] |
van der Weijden MA, Claushuis TA, Nazari T, et al. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review[J]. Clin Rheumatol, 2012, 31(11): 1529-1535.
doi: 10.1007/s10067-012-2018-0 pmid: 22706444 |
| [19] |
Gamsjaeger S, Srivastava AK, Wergedal JE, et al. Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links[J]. J Bone Miner Res, 2014, 29(11): 2382-2391.
doi: 10.1002/jbmr.2268 pmid: 24771481 |
| [20] |
Kim SC, Paik JM, Liu J, et al. Gout and the risk of non-vertebral fracture[J]. J Bone Miner Res, 2017, 32(2): 230-236.
doi: 10.1002/jbmr.2978 URL |
| [21] |
Ceccarelli F, Perricone C, Colasanti T, et al. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus[J]. Arthritis Res Ther, 2018, 20(1): 126.
doi: 10.1186/s13075-018-1622-z pmid: 29898764 |
| [22] |
Cramarossa G, Urowitz MB, Su J, et al. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus[J]. Lupus, 2017, 26(4):365-372.
doi: 10.1177/0961203316664597 pmid: 27522094 |
| [23] |
Ruaro B, Casabella A, Paolino S, et al. Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score(TBS)[J]. Clinical Rheumatol, 2018, 37(11):3057-3062.
doi: 10.1007/s10067-018-4322-9 URL |
| [24] | Hu Z, Zhu S, Zhang B. Impaired bone health in patients with primary Sjogren’s syndrome[EB/J]. Arthritis Rheumatol, 2016. https://acrabstracts.org/abstract/impaired-bone-health-in-patients-with-primary-sjogrens-syndrome/. |
| [25] |
Englund M, Merkel PA, Tomasson G, et al. Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population[J]. J Rheumatol, 2016, 43(8): 1553-1558.
doi: 10.3899/jrheum.151151 pmid: 27252425 |
| [26] |
Robson J, Doll H, Suppiah R, et al. Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials[J]. Ann Rheum Dis, 2015, 74(1): 177-184.
doi: 10.1136/annrheumdis-2013-203927 URL |
| [27] |
Raterman HG, Lems WF. Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide[J]. Drugs Aging, 2019, 36(12): 1061-1072.
doi: 10.1007/s40266-019-00714-4 pmid: 31541358 |
| [28] | Maxwell LJ, Zochling J, Boonen A, et al. TNF-alpha inhibitors for ankylosing spondylitis[J]. Cochrane Database Syst Rev, 2015(4): CD005468. |
| [29] | Chen YM, Chen HH, Huang WN, et al. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis[J]. PLoS One, 2017, 12(11): e0188454. |
| [30] |
Dubrovsky AM, Lim MJ, Lane NE. Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton[J]. Calcif Tissue Int, 2018, 102(5): 607-618.
doi: 10.1007/s00223-018-0401-9 URL |
| [31] |
Chen XD, Xiao P, Lei SF, et al. Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians[J]. J Bone Miner Res, 2010, 25(2): 339-355.
doi: 10.1359/jbmr.090724 URL |
| [32] |
Zhou H, Newnum AB, Martin JR, et al. Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species[J]. Bone, 2011, 49(3): 404-411.
doi: 10.1016/j.bone.2011.04.020 URL |
| [33] |
Solomon DH, Kay J, Duryea J, et al. Effects of teriparatide on joint erosions in rheumatoid arthritis: a randomized controlled trial[J]. Arthritis Rheumatol, 2017, 69(9): 1741-1750.
doi: 10.1002/art.40156 URL |
| [34] |
Yue J, Griffith JF, Xiao F, et al. Repair of bone erosion in rheumatoid arthritis by denosumab: a high-resolution peripheral quantitative computed tomography study[J]. Arthritis Care Res (Hoboken), 2017, 69(8):1156-1163.
doi: 10.1002/acr.23133 URL |
| [35] |
Ostrovsky V, Malnick S, Ish-Shalom S, et al. Denosumab-induced immune hepatitis[J]. Biomedicines, 2021, 9(1): 76.
doi: 10.3390/biomedicines9010076 URL |
| [1] | ZHOU Yi, CHEN Ying, CHEN Erzhen. Research progress of thyroid hormone on organ function maintenance in sepsis [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 408-412. |
| [2] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 339-343. |
| [3] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 262-266. |
| [4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 258-261. |
| [5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 202-207. |
| [6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 186-189. |
| [7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 190-194. |
| [8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 267-272. |
| [9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 270-271. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
